ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,647.55
0.29%
Dow Jones
40,797.92
1.46%
US Dollar vs MXN
17.7016
-0.16%
Brent Oil
83.445
-1.06%
Bitcoin
64,413.71
-0.68%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Co Diagnostics Inc (CODX)

  7. Co Diagnostics Inc (CODX) Noticias

CODX

Co Diagnostics (CODX)

Co Diagnostics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CODX
FechaHoraFuenteTítuloSímboloCompañía
13/03/202007:00Business WirePreCheck Health to Exclusively Distribute Coronavirus COVID-19 Test in Ecuador, a Population of 16 Million, for Co-Diagnostic...NASDAQ:CODXCo Diagnostics Inc
12/03/202005:30Business WireCo-Diagnostics, Inc Chief Scientific Officer to Address Bipartisan Commission on Biodefense in Washington, D.C.NASDAQ:CODXCo Diagnostics Inc
11/03/202008:30GlobeNewswire Inc.Buy for Co-Diagnostics (NASDAQ:CODX) Reiterated by H.C. Wainwright with $20 Price TargetNASDAQ:CODXCo Diagnostics Inc
06/03/202012:01GlobeNewswire Inc.Co-Diagnostics (NASDAQ:CODX) Ready to Meet U.S Vice President’s Plea for More Domestic TestsNASDAQ:CODXCo Diagnostics Inc
05/03/202005:30Business WireCo-Diagnostics, Inc. Reports Additional Demand for Coronavirus Test ShipmentsNASDAQ:CODXCo Diagnostics Inc
03/03/202005:30Business WireCo-Diagnostics, Inc. Invited to Speak on Coronavirus at Molecular Med Tri-Con in San FranciscoNASDAQ:CODXCo Diagnostics Inc
02/03/202010:51Business WireCo-Diagnostics Announces Closing of $4.2 Million Registered Direct Offering Priced At-the-MarketNASDAQ:CODXCo Diagnostics Inc
02/03/202005:30Business WireCo-Diagnostics, Inc. to Provide COVID-19 Tests to US CLIA Labs Following FDA Policy ChangeNASDAQ:CODXCo Diagnostics Inc
28/02/202016:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CODXCo Diagnostics Inc
27/02/202016:56Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CODXCo Diagnostics Inc
27/02/202006:16Business WireCo-Diagnostics Announces $4.2 Million Registered Direct Offering Priced At-the-MarketNASDAQ:CODXCo Diagnostics Inc
24/02/202014:37Business WireCo-Diagnostics, Inc. Receives CE Mark for Novel Coronavirus TestNASDAQ:CODXCo Diagnostics Inc
20/02/202013:33Business WireCo-Diagnostics Completes Submission of CE Marking Registration for COVID-19 Coronavirus TestNASDAQ:CODXCo Diagnostics Inc
19/02/202005:30Business WireCo-Diagnostics Announces New Vector Control Orders and Continued Progress Toward Regulatory Clearance for Coronavirus TestNASDAQ:CODXCo Diagnostics Inc
18/02/202006:00GlobeNewswire Inc.Co-Diagnostics (NASDAQ:CODX) Helping to Mitigate Global Economic RiskNASDAQ:CODXCo Diagnostics Inc
13/02/202009:56Business Wire Co-Diagnostics Announces Closing of $10.2 Million Registered Direct Offering Priced At-the-MarketNASDAQ:CODXCo Diagnostics Inc
13/02/202005:30Business WireCo-Diagnostics, Inc. to Present its Rapid Response to New Coronavirus in Washington D.C. ConferenceNASDAQ:CODXCo Diagnostics Inc
11/02/202007:00Business WireCo-Diagnostics Announces $10.2 Million Registered Direct Offering Priced At-the-MarketNASDAQ:CODXCo Diagnostics Inc
10/02/202014:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CODXCo Diagnostics Inc
10/02/202013:07Business WireCo-Diagnostics, Inc. Announces Sales of New Coronavirus TestNASDAQ:CODXCo Diagnostics Inc
06/02/202014:30Business WireCo-Diagnostics, Inc. Announces Launch of Test for New CoronavirusNASDAQ:CODXCo Diagnostics Inc
04/02/202005:30Business WireCo-Diagnostics Inc to Discuss New Coronavirus Test During GenomeWeb Webinar on Feb 5NASDAQ:CODXCo Diagnostics Inc
31/01/202014:35Business WireCo-Diagnostics, Inc. Announces Successful Initial Verification of Novel Coronavirus TestNASDAQ:CODXCo Diagnostics Inc
30/01/202010:20Business WireCo-Diagnostics, Inc. CEO Interviewed on Fox Business with Maria Bartiromo as Coronavirus Concerns RiseNASDAQ:CODXCo Diagnostics Inc
28/01/202012:21Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CODXCo Diagnostics Inc
28/01/202008:45Business WireCo-Diagnostics Announces Closing of $5 Million Registered Direct Offering Priced At-the-MarketNASDAQ:CODXCo Diagnostics Inc
28/01/202005:30Business WireCo-Diagnostics Inc CEO Discusses Novel Coronavirus with CNBC Squawk Box AsiaNASDAQ:CODXCo Diagnostics Inc
24/01/202007:00Business WireCo-Diagnostics Announces $5.0 Million Registered Direct Offering Priced At-the-MarketNASDAQ:CODXCo Diagnostics Inc
23/01/202014:05GlobeNewswire Inc.Co-Diagnostics (NASDAQ:CODX) Prepares Coronavirus Test as World Health Organization Weighs Global Health EmergencyNASDAQ:CODXCo Diagnostics Inc
23/01/202005:30Business WireCo-Diagnostics, Inc. Designs Test for New Coronavirus Using CoPrimer™ PlatformNASDAQ:CODXCo Diagnostics Inc
 Showing the most relevant articles for your search:NASDAQ:CODX

Su Consulta Reciente

USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
GOOGL
Alphabet
NYSE
JPM
JP Morgan Chase
NASDAQ
MSFT
Microsoft
USOTC
ADDYY
Adidas (QX)
NASDAQ
TSLA
Tesla
NYSE
AXP
American Express
NYSE
MCD
McDonalds
NYSE
CVX
Chevron
NYSE
KO
Coca Cola
NYSE
BAC
Bank of America
NYSE
MRK
Merck
AMEX
XLF
Financial Select Sector
AMEX
XLE
Energy Select Sector SPDR
CCOM
US500
US 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados